| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.2B | $2.7B | $2.5B | $2.2B | $1.9B | $0.4B | $0.4B | $0.3B |
| Cost of Revenue | $0.7B | $0.6B | $0.5B | $0.4B | $0.4B | $0.1B | $0.1B | $0.1B |
| Gross Profit | $2.6B | $2.2B | $2.0B | $1.8B | $1.6B | $0.4B | $0.3B | $0.2B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $-0.1B | $0.0B | $0.3B | $0.5B | $0.4B | $0.1B | $0.1B | $0.1B |
| Net Income | $0.0B | $0.1B | $0.4B | $0.4B | $0.3B | $0.0B | $0.1B | $0.1B |
| EPS (Basic) | $0.02 | $0.34 | $0.92 | $0.93 | $0.75 | $0.91 | $2.42 | $2.31 |
| EPS (Diluted) | $0.02 | $0.34 | $0.92 | $0.93 | $0.74 | $0.91 | $2.39 | $2.29 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $10.5B | $9.3B | $8.9B | $8.4B | $7.3B | $6.9B | $3.9B | $3.3B |
| Current Assets | $2.1B | $5.0B | $5.5B | $5.2B | $4.0B | $3.9B | $1.2B | $1.2B |
| Cash & Equivalents | $1.6B | $4.7B | $5.2B | $5.0B | $3.8B | $3.7B | $1.1B | $1.1B |
| Total Liabilities | $2.2B | $1.7B | $1.6B | $1.5B | $1.5B | $1.5B | $0.4B | $0.3B |
| Current Liabilities | $0.7B | $0.6B | $0.5B | $0.4B | $0.3B | $0.3B | $0.2B | $0.2B |
| Stockholders' Equity | $8.3B | $7.6B | $7.3B | $6.9B | $5.7B | $5.4B | $3.4B | $3.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.4B | $0.5B | $0.5B | $0.5B | $0.5B | $0.5B | $0.3B |
| Investing Cash Flow | $-2.8B | $-0.9B | $-0.2B | $-0.1B | $-0.4B | $-0.5B | $-0.5B | $-0.4B |
| Capital Expenditures | $0.3B | $0.6B | $0.1B | $0.0B | $0.1B | — | — | — |
| Financing Cash Flow | $-0.6B | $-0.0B | $-0.0B | $0.7B | $-0.0B | $2.7B | $-0.0B | $0.0B |